|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.25 INR | +1.05% |
|
+40.69% | +95.40% |
| 08-05 | Morepen Laboratories Limited announces Annual dividend, payable on October 26, 2026 | CI |
| 08-04 | Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 18.52B 195M 168M 157M 144M 271M 276M 1.84B 724M 9.28B 731M 715M 30.69B | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.52B 195M 168M 157M 144M 271M 276M 1.84B 724M 9.28B 731M 715M 30.69B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
57.31% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | +1.05% | ||
| 1 week | +40.69% | ||
| Current month | +40.69% | ||
| 1 month | +31.15% | ||
| 3 months | +82.26% | ||
| 6 months | +118.72% | ||
| Current year | +95.40% |
| 1 week | 55.91 |  | 83.5 |
| 1 month | 51.38 | | 83.5 |
| Current year | 33.05 | | 83.5 |
| 1 year | 33.05 | | 83.5 |
| 3 years | 31.3 | | 100.9 |
| 5 years | 23.6 | | 100.9 |
| 10 years | 7.2 | | 100.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 58 | 01/07/2026 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 01/02/1992 |
| Director of Finance/CFO | 59 | 03/04/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 01/02/1992 |
| Director/Board Member | 58 | 13/08/2019 | |
Savita
BRD | Director/Board Member | - | 22/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.05% | +40.69% | - | - | 461M | |
| -0.52% | +3.21% | +85.02% | +161.12% | 1,057B | |
| +0.88% | +1.13% | +51.13% | +49.76% | 625B | |
| +0.89% | -1.95% | +23.73% | +63.67% | 435B | |
| +0.71% | +3.87% | +47.45% | +38.68% | 363B | |
| +0.64% | -0.49% | +35.39% | +40.21% | 296B | |
| +0.39% | -5.83% | +8.64% | +9.28% | 249B | |
| +1.51% | +6.69% | +44.34% | +62.47% | 222B | |
| +3.92% | -0.46% | -1.21% | -44.09% | 209B | |
| +1.80% | +2.30% | +20.79% | +65.13% | 165B | |
| Average | +1.29% | +0.87% | +35.03% | +49.58% | 402.31B | |
| Weighted average by Cap. | +1.12% | +1.22% | +48.34% | +75.33% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.02B 179M 155M 144M 133M 249M 253M 1.69B 665M 8.53B 672M 657M 28.2B | 18.12B 190M 165M 154M 141M 265M 270M 1.8B 708M 9.08B 715M 699M 30.02B |
| Net income | 962M 10.1M 8.74M 8.16M 7.49M 14.08M 14.31M 95.76M 37.58M 482M 37.94M 37.11M 1.59B | 1.18B 12.4M 10.73M 10.02M 9.19M 17.28M 17.56M 118M 46.13M 592M 46.57M 45.55M 1.96B |
| Net Debt | 121M 1.27M 1.1M 1.02M 939K 1.77M 1.79M 12M 4.71M 60.42M 4.76M 4.65M 200M | -928K -9.75K -8.43K -7.88K -7.23K -13.59K -13.81K -92.41K -36.27K -465K -36.62K -35.81K -1.54M |
Employees
1,814
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | ₹80.25 | +1.05% | 36,485,619 |
| 06/08/26 | ₹79.42 | +3.21% | 100,581,767 |
| 05/08/26 | ₹76.95 | +11.23% | 119,149,669 |
| 04/08/26 | ₹69.18 | +20.00% | 67,096,271 |
| 03/08/26 | ₹57.65 | +1.07% | 5,950,210 |
- Stock Market
- Stocks
- MOREPENLAB Stock
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
